TrialBritish journal of cancer2014

Intra- and postoperative catumaxomab in patients with epithelial ovarian cancer: safety and two-year efficacy results from a multicentre, single-arm, phase II study.

J Sehouli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.